Session # n/a

Gender bias: Underdiagnosing hereditary cancer in men with prostate cancer

Men and women are equally likely to carry mutations in hereditary cancer genes and both have elevated cancer risks. Despite this, over 96% of patients undergoing hereditary cancer multi-gene panel testing (MGPT) are women. Prostate cancer (PC) is associated with mutations in CHEK2, ATM, BRCA1 and BRCA2 (BRCA), and National Comprehensive Cancer Network (NCCN) recommendations for early screening exist for mutation carriers. We sought to describe the mutation spectrum and MGPT uptake in men with PC as compared to women with breast cancer (BC).

• Authors: Lauren Bowling; Patrick Reineke; Rachel McFarland; Shuwei Li; Emily Dalton; Jill Dolinsky
• Conference: ASCO 2016
• Date: Tuesday, Feb 16, 2016 5:15pm - 6:15pm